Agrifood

Over-regulating gene editing slows down innovation, Bayer says

An extensive regulatory process on gene editing adds more bureaucracy, increasing costs and slowing down innovation, Liam Condon, President of Bayer’s crop science division told EURACTIV.com.

This article is part of our special report A difficult balance: Science, politics and policy-making on food

Access the full report

The new company accounts, pro forma, €20 billion from sales and has a R&D budget of €2 billion, engaging 8,000 scientists. [Gerardo Fortuna]

Gerardo Fortuna Euractiv 24-09-2018 07:58 5 min. read Content type: Euractiv is part of the Trust Project
Share
Facebook X LinkedIn Mail

This article is part of our special report A difficult balance: Science, politics and policy-making on food.

Donec et orci aliquet nisl suscipit molestie sed sit amet tortor. Duis vel urna ac mi sollicitudin lacinia mollis sit amet lorem. Sed finibus erat nec libero scelerisque fringilla. Morbi at orci sed urna vulputate vulputate. Nulla facilisi. Donec et orci aliquet nisl suscipit molestie sed sit amet tortor.

Want to keep reading?

Get a subscription on Euractiv Pro and elevate your political insight!

Discover Euractiv Pro
For corporations

Updated: 29-09-2024

Topics  

More from this section

Agrifood

Top deforestation drivers could dodge ‘high risk’ tag under EU benchmarking

03/10/2024

3 min. read

Agrifood

Fishing suspension in Bay of Biscay sparks criticism by the European fishermen

03/10/2024

4 min. read

Agrifood

Delay in EU anti-deforestation enforcement leaves little time to make changes

02/10/2024

4 min. read

More from this author

Health

WHO lobbies EU lawmakers against watering down alcohol cancer risk

07/11/2023

6 min. read

Agrifood

Agrifood Brief: NGTs in the UK

03/11/2023

9 min. read

Agrifood

Agrifood Brief: A topsy-turvy Parliament

20/10/2023

11 min. read

Subscribe to our newsletters

Subscribe